Adverse effects of antipsychotics as outcome measures
نویسندگان
چکیده
منابع مشابه
Adverse Effects of Antipsychotics and Mood Stabilizers
In recent years, the adverse effects of second-generation antipsychotics on body weight have become a significant concern for clinicians and their patients; however, other metabolic effects of these drugs, as well as metabolic effects of first-generation antipsychotics and mood stabilizers, also require our attention and awareness. In this article we focus on the phenomenology, evaluation, and ...
متن کاملSecond-Generation Antipsychotics and Extrapyramidal Adverse Effects
Antipsychotic-induced extrapyramidal adverse effects are well recognized in the context of first-generation antipsychotic drugs. However, the introduction of second-generation antipsychotics, with atypical mechanism of action, especially lower dopamine receptors affinity, was met with great expectations among clinicians regarding their potentially lower propensity to cause extrapyramidal syndro...
متن کاملA review of the adverse side effects associated with antipsychotics as related to their efficacy.
Since the introduction of antipsychotic medication for the treatment of psychosis, a wide range of different types of antipsychotic drugs have been developed while their side effects have become evident. The side effects of both the typical and atypical generation of antipsychotics have important consequences for the quality of life of recipients, stigma experienced and also the level of care o...
متن کاملAntipsychotics and Pregnancy Outcome
New safety information has been added to the prescribing information for desipramine (Norpramin). The updated label now states "extreme caution should be used when this drug is given to patients who have a family history of sudden death, cardiac dysrhythmias, and cardiac conduction disturbances; and that seizures precede cardiac dysrhythmias and death in some patients." The label also warns tha...
متن کاملAdverse events associated with switching antipsychotics.
Antipsychotics are the first-line agents for managing schizophrenia and related disorders. As with other chronic illnesses, clinicians must often decide whether to switch a patient’s current medication to try to improve treatment response, reduce intolerable side effects and improve quality of life and functioning. Unfortunately, guidance for switching among antipsychotics is lacking, as minima...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Psychiatry
سال: 2007
ISSN: 0007-1250,1472-1465
DOI: 10.1192/bjp.191.50.s64